Greetings to all and sundry,It is a beautiful day today and an exciting time not just to learn but to share and imbibe knowledge. It is always such a pleasure to be heard, and I am glad that I get to that even though we all have lots of stuff we are handling in our individual lives.I hope we are all doing well and having an amazing month, I miss my readers and I hope you miss me too. Today I want to talk about a thesis project I worked on in my final days in school and share my thoughts on what I think the future holds or what could be done in the healthcare sector for this.Healthcare and Research are not exclusive of each other or shouldn't be exclusive of each other because it is through research that medical procedures get to be refined, knowing what works well and what is failing with time, coming up with new techniques, new inventions, new ways of doing things, refining drugs, etc.In this research, I looked at the prevalence of an infant condition that presents on the eye which has significant morbidity and tends to be quite prevalent in developing nations like Ghana. Prevalence of Ophthalmia NeonatorumBacterial conjunctivitis is inflammation of the conjunctiva caused by bacteria with the most common isolates being Streptococcus pneumoniae, Staphylococcus aureus, Haemophilus influenzae, and Moraxella catarrhalis. Patients present with conjunctival congestion, grittiness, burning sensation, and mucopurulent discharge. When this occurs within the first month of life it is called ophthalmia neonatorum, also known as neonatal conjunctivitis. In Africa and Ghana, ophthalmia neonatorum (ON) is a public health concern, especially in areas with poor socioeconomic status and limited access to healthcare facilities. According to Amnesty et all, Variable prevalence rates of ON have been recorded in studies conducted throughout Africa, ranging from 2% to 20% with higher rates noted in underserved and rural communities. Due to difficulties with maternal healthcare, insufficient prenatal screening,